Is Johnson & Johnson an Underdog in the COVID-19 Vaccine Race?
You won't have a very difficult time identifying ways that Johnson & Johnson (NYSE: JNJ) is a leader. It's the largest healthcare company in the world with a market cap of close to $400 billion. Johnson & Johnson announced in March that it would invest more than $1 billion to develop a COVID-19 vaccine candidate.